[HTML][HTML] Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study
…, A Trachalaki, E Vasarmidi, J Organtzis… - ERJ open …, 2020 - Eur Respiratory Soc
Nintedanib is a tyrosine kinase inhibitor approved for the treatment of idiopathic pulmonary
fibrosis (IPF). In a retrospective, real-world study across seven Greek hospitals, we evaluated …
fibrosis (IPF). In a retrospective, real-world study across seven Greek hospitals, we evaluated …